These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37195698)

  • 21. Design and Reporting Considerations for Genetic Screening Tests.
    Hagenkord J; Funke B; Qian E; Hegde M; Jacobs KB; Ferber M; Lebo M; Buchanan A; Bick D
    J Mol Diagn; 2020 May; 22(5):599-609. PubMed ID: 32092541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing in the European Union: does economic evaluation matter?
    Antoñanzas F; Rodríguez-Ibeas R; Hutter MF; Lorente R; Juárez C; Pinillos M
    Eur J Health Econ; 2012 Oct; 13(5):651-61. PubMed ID: 21598012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying persons with Lynch syndrome: why and how?
    Ladabaum U
    Dig Dis Sci; 2014 Dec; 59(12):2841-4. PubMed ID: 25344908
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
    Goldhaber-Fiebert JD; Stout NK; Salomon JA; Kuntz KM; Goldie SJ
    J Natl Cancer Inst; 2008 Mar; 100(5):308-20. PubMed ID: 18314477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [When is screening economically beneficial?].
    Sintonen H
    Duodecim; 2000; 116(8):902-8. PubMed ID: 11787134
    [No Abstract]   [Full Text] [Related]  

  • 29. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consecutive medical exome analysis at a tertiary center: Diagnostic and health-economic outcomes.
    Kosaki R; Kubota M; Uehara T; Suzuki H; Takenouchi T; Kosaki K
    Am J Med Genet A; 2020 Jul; 182(7):1601-1607. PubMed ID: 32369273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
    Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
    N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General session: cost-effectiveness of screening for genetic predisposition to diseases of adult onset.
    Rotter JI
    J Insur Med; 1993; Suppl B():216-28. PubMed ID: 10146357
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
    Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
    JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.
    Goldie SJ; Kuntz KM; Weinstein MC; Freedberg KA; Welton ML; Palefsky JM
    JAMA; 1999 May; 281(19):1822-9. PubMed ID: 10340370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 36. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.
    JAMA; 1998 Nov; 280(20):1757-63. PubMed ID: 9842951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.
    Phillips KA; Pletcher MJ; Ladabaum U
    Technol Health Care; 2015; 23(3):373-9. PubMed ID: 25669213
    [No Abstract]   [Full Text] [Related]  

  • 38. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic tests for low- and middle-income countries: a literature review.
    Maltese PE; Poplavskaia E; Malyutkina I; Sirocco F; Bonizzato A; Capodicasa N; Nicoulina SY; Salmina A; Aksutina N; Dundar M; Beccari T; Cecchin S; Bertelli M
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28198508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
    Shapiro AJ; Kroener L; Quinn MM
    J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.